Stimcell Energetics (STME) Operating Income (2016 - 2024)
Stimcell Energetics' (STME) quarterly Operating Income came in at -$116961.0 in Q2 2024, down 80.57% year-on-year from -$601979.7 in Q2 2023, and down 102.44% quarter-over-quarter from -$57775.0 in Q1 2024.
Stimcell Energetics (STME) Operating Income (2016 - 2024) Analysis & Trends
Stimcell Energetics' Operating Income history runs 9 years deep, the most recent figure standing at -$116961.0 for Q2 2024.
- On a quarterly basis, Operating Income fell 80.57% year-over-year to -$116961.0 in Q2 2024; TTM through May 2024 was -$268352.0, a 40.05% increase from a year earlier, with the FY2024 full-year figure at -$268352.0, up 40.05% from the prior year.
- Operating Income retreated to -$116961.0 in Q2 2024 per STME's latest filing, from -$57775.0 in the prior quarter.
- Across five years, Operating Income topped out at -$42562.0 in Q4 2023 and bottomed at -$254240.0 in Q1 2020.
- The 5-year median for Operating Income is -$149555.0 (2022), against an average of -$145176.1.
- Biggest YoY gain for Operating Income was 79.55% in 2020; the steepest drop was 252.18% in 2020.
- Year by year, Operating Income stood at -$181457.0 in 2020, then rose by 6.02% to -$170535.0 in 2021, then climbed by 22.57% to -$132049.0 in 2022, then surged by 67.77% to -$42562.0 in 2023, then slumped by 174.8% to -$116961.0 in 2024.
- Per Business Quant, the three latest STME Operating Income figures stand at -$116961.0 (Q2 2024), -$57775.0 (Q1 2024), and -$42562.0 (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -116,961.00 |
| Feb 29, 2024 | -57,775.00 |
| Nov 30, 2023 | -42,562.00 |
| Aug 31, 2023 | -51,054.00 |
| May 31, 2023 | -64,773.00 |
| Feb 28, 2023 | -105,832.00 |
| Nov 30, 2022 | -132,049.00 |
| Aug 31, 2022 | -145,004.00 |
| May 31, 2022 | -154,106.00 |
| Feb 28, 2022 | -112,640.00 |
| Nov 30, 2021 | -170,535.00 |
| Aug 31, 2021 | -234,412.00 |
| May 31, 2021 | -178,967.00 |
| Feb 28, 2021 | -169,975.00 |
| Nov 30, 2020 | -181,457.00 |
| Aug 31, 2020 | -194,756.00 |
| May 31, 2020 | -246,071.00 |
| Feb 29, 2020 | -254,240.00 |
| Nov 30, 2019 | -299,705.00 |
| Aug 31, 2019 | -238,335.00 |